Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo

Oncogene

Volumn 17, Issue 17, 1998, Pages 2167-2175

  Deng, Jiong ^a   Xia, Weiya ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adenovirus 5 E1A; Apoptosis; Murine melanoma; Tumor suppression

Indexed keywords

ANTINEOPLASTIC AGENT; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; TUMOR GROWTH;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HUMAN ADENOVIRUS TYPE 5; MURINAE;

EID: 0032578861     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202148     Document Type: Article

References (58)

1. Bellamy COC, Malcomson RDG, Harrison DJ and Wyllie AH. (1995). Seminars in Cancer Biol., 6, 3-16.
2. Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson DW, Poirier GG and Shore GC. (1996). Oncogene, 12, 529-535.
3. Canman CE and Kastan M. (1995). Seminars Cancer Biol., 6, 17-25.
4. Chang JY, Xia W, Shao R and Hung MC. (1996). Oncogene, 13, 1405-1412.
5. Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L and Hung MC. (1997). Oncogene, 14, 561-568.
6. Chen H and Hung MC. (1997). J. Biol. Chem. 272, 6101-6104.
7. Chen H, Yu D, Chinnadura G, Karunagaran D and Hung MC. (1997). Oncogene, 14, 1965-1971.
8. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P and Linsley PS. (1992). Cell, 71, 1093-1102.
9. Chen MJ, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M and Shalloway D. (1987). Nature, 330, 581-583.
10. Chen PM and Ananthaswamy HN. (1993). J. Immunol., 151, 244-255.
11. Chu G. (1994). J. Biol. Chem., 269, 787-790.
12. Cook JL, May DL, Wilson BA, Holskin B, Chen M, Shalloway D and Walker TA. (1989). J Immunol., 142, 4527-4534.
13. Debbas M and White E. (1993). Gene Dev., 7, 546-554.
14. Desoize B. (1994). Anticancer Res., 14, 2291-2294.
15. Duerksen-Hughes P, Wold WSM and Gooding LR. (1989). J. Immunol., 143, 4193-4200.
16. Donawho CK, Muller HK, Bucana CD and Kripke ML. (1996). J. Immunol., 157, 781-786.
17. Frisch SM. (1991). Proc. Natl. Acad. Sci. USA, 88, 9077-9081.
18. Frisch SM. (1994). J. Cell. Biol., 124, 619-624.
19. Frisch SM and Dolter KE. (1995). Cancer Res., 55, 5551-5555.
20. Gavrieli I, Sherman Y and Ben-Sasson SA. (1992). J. Cell Biol., 119, 493-501.
21. Glinsky GV and Glinsky VV. (1996). Cancer Lett., 101, 43-51.
22. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. (1996). Nature, 379, 88-91.
23. Graham F and van der Eb A. (1973). Virology, 52, 456-467.
24. Gutman M, Singh RK, Xie K, Bucana CD and Filder IJ. (1995). Cancer Res., 55, 2470-2475.
25. Hirt B. (1967). J. Mol. Biol., 26, 365-369.
26. Houwelling A, van den Elsen PJ and van der Eb AJ. (1980). Virology, 105, 537-550.
27. Jansen B, Schlagbauer-Wadl H, Eichler H-G, van Elsas A., Schrier PI and Pehamberger H. (1997). Cancer Res., 57, 362-365.
28. Kerbel RS. (1994-95). Invasion Metastasis, 14, 50-60.
29. Kripke M. (1979). J. Natl. Ca. Inst., 63, 541-545.
30. Liebermann DA, Hoffman B and Steinman RA. (1995). Oncogene, 11, 199-210.
31. Lowe SW and Ruley HE. (1993). Gene Dev., 7, 535-545.
32. Mymryk JS, Shire K and Bayley ST. (1994). Oncogene, 9, 1187-1193.
33. Mymryk, JS. (1996). Oncogene, 13, 1581-1589.
34. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C. (1991). J. Immunol. Methods, 139, 271-279.
35. Peeper DS and Zantema A. (1993). Mol. Biol. Reports., 17, 197-207.
36. Peris K, Cerroni L, Chimenti S, Soyer HP, Kerl H and Hofler H. (1991). Arch. Dermatol. Res., 283, 500-503.
37. Pierceall WE, Kripke ML and Ananthaswamy HN. (1992). Cancer Res., 52, 3946-3951.
38. Pozzatti R, Muschel R, Williams J, Padmanabhan R, Howard B, Liotta L and Khoury G. (1986). Science, 232, 223-227.
39. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E. (1992). Proc. Natl. Acad. Sci. USA, 89, 7742-7746.
40. Ruley HE. (1983). Nature, 304, 602-606.
41. Sanchez-Prieto R, Lleonart M and Cajal. (1995). Oncogene, 10, 675-682.
42. Sanchez-Prieto R, Quintanilla M, Cano AR, Lleonart M, Martin P, Anaya A and Cajal SR. (1996). Oncogene, 13, 1083-1092.
43. Shih I-M and Herlyn M. (1993). J. Invest. Dermatol., 100, 196S-203S.
44. Shisler J, Duerksen-Hughes P, Hermiston TM, Wold WS and Gooding LR. (1996). J. Virol., 70, 68-77.
45. Smets L. (1994). Anti-Cancer Drugs, 5, 3-9.
46. Teodoro JG, Shore GC and Branton PE. (1995). Oncogene, 10, 467-474.
47. Townsend SE and Allison JP. (1993). Science, 259, 368-370.
48. Trent JC II, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A and Ananthaswamy HN. (1996). EMBO J., 15, 4459-4505.
49. Tsuji Y, Ninomiya-Tsuji J, Torti SV and Torti FM. (1993). J. Immunol., 150, 1897-1907.
50. White E, Grodzicker T and Stillman BW. (1984). J. Virol., 52, 410-419.
51. White E and Stillman B. (1987). J. Virol., 61, 426-435.
52. Williams GT. (1991). Cell, 65, 1097-1098.
53. Wu J. (1996). Anticancer Res., 16, 2233-2240.
54. Xie K, Huang S, Dong Z, Juang S-H, Gutman M, Xie Q-W, Nathan C and Filder IJ. (1995). J. Exp. Med., 181, 1333-1343.
55. Yu D, Suen TC, Yan DH, Chang LS and Hung MC. (1990). Proc. Natl. Acad. Sci. USA, 87, 4499-4503.
56. Yu D, Hamada J-I, Zhang H, Nicolson GL and Hung MC. (1992). Oncogene, 7, 2263-2270.
57. Yu D, Wolf JK, Scanlon M, Price JE and Hung M-C. (1993). Cancer Res., 53, 891-898.
58. Zhang Y, Yu D, Xia W and Hung M-C. (1995). Oncogene, 10, 1947-1954.